NCT01076192View on ClinicalTrials.gov

Study of Adalimumab (HUMIRA®) in Patients With Moderate to Severe Psoriasis (PS) in Spain (PROMISE)

CompletedOBSERVATIONAL
Enrollment

547

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Moderate-to-severe Chronic Plaque Psoriasis
Sponsors

Collaborators (1)

IMS Health
All Listed Sponsors
collaborator

IMS Health

OTHER

lead

AbbVie (prior sponsor, Abbott)

INDUSTRY

NCT01076192 - Study of Adalimumab (HUMIRA®) in Patients With Moderate to Severe Psoriasis (PS) in Spain (PROMISE) | Biotech Hunter | Biotech Hunter